A citation-based method for searching scientific literature

Jacson K Shen, Gregory M Cote, Yan Gao, Edwin Choy, Henry J Mankin, Francis J Hornicek, Zhenfeng Duan. Sci Rep 2016
Times Cited: 38







List of co-cited articles
380 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Histone deacetylase inhibitors reverse SS18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma.
Joanna M Lubieniecka, Diederik R H de Bruijn, Le Su, Anke H A van Dijk, Subbaya Subramanian, Matt van de Rijn, Neal Poulin, Ad Geurts van Kessel, Torsten O Nielsen. Cancer Res 2008
89
23

Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation.
Boris G Wilson, Xi Wang, Xiaohua Shen, Elizabeth S McKenna, Madeleine E Lemieux, Yoon-Jae Cho, Edward C Koellhoffer, Scott L Pomeroy, Stuart H Orkin, Charles W M Roberts. Cancer Cell 2010
403
23

Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics.
Le Su, Arthur V Sampaio, Kevin B Jones, Marina Pacheco, Angela Goytain, Shujun Lin, Neal Poulin, Lin Yi, Fabio M Rossi, Juergen Kast,[...]. Cancer Cell 2012
106
23

Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
Satoshi Kawano, Alexandra R Grassian, Masumi Tsuda, Sarah K Knutson, Natalie M Warholic, Galina Kuznetsov, Shanqin Xu, Yonghong Xiao, Roy M Pollock, Jesse S Smith,[...]. PLoS One 2016
42
23

A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells.
Sarah K Knutson, Tim J Wigle, Natalie M Warholic, Christopher J Sneeringer, Christina J Allain, Christine R Klaus, Joelle D Sacks, Alejandra Raimondi, Christina R Majer, Jeffrey Song,[...]. Nat Chem Biol 2012
567
21

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.
Michael T McCabe, Heidi M Ott, Gopinath Ganji, Susan Korenchuk, Christine Thompson, Glenn S Van Aller, Yan Liu, Alan P Graves, Anthony Della Pietra, Elsie Diaz,[...]. Nature 2012
21

The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma.
Matthew J McBride, John L Pulice, Hannah C Beird, Davis R Ingram, Andrew R D'Avino, Jack F Shern, Gregory W Charville, Jason L Hornick, Robert T Nakayama, Enrique M Garcia-Rivera,[...]. Cancer Cell 2018
106
21

Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma.
J Clark, P J Rocques, A J Crew, S Gill, J Shipley, A M Chan, B A Gusterson, C S Cooper. Nat Genet 1994
601
18

Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.
Sarah K Knutson, Natalie M Warholic, Tim J Wigle, Christine R Klaus, Christina J Allain, Alejandra Raimondi, Margaret Porter Scott, Richard Chesworth, Mikel P Moyer, Robert A Copeland,[...]. Proc Natl Acad Sci U S A 2013
484
18

Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma.
Sarah K Knutson, Satoshi Kawano, Yukinori Minoshima, Natalie M Warholic, Kuan-Chun Huang, Yonghong Xiao, Tadashi Kadowaki, Mai Uesugi, Galina Kuznetsov, Namita Kumar,[...]. Mol Cancer Ther 2014
363
18

Targeting EZH2 in cancer.
Kimberly H Kim, Charles W M Roberts. Nat Med 2016
784
18

A conditional mouse model of synovial sarcoma: insights into a myogenic origin.
Malay Haldar, Jeffrey D Hancock, Cheryl M Coffin, Stephen L Lessnick, Mario R Capecchi. Cancer Cell 2007
218
15

Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.
Cigall Kadoch, Diana C Hargreaves, Courtney Hodges, Laura Elias, Lena Ho, Jeff Ranish, Gerald R Crabtree. Nat Genet 2013
762
15

SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2.
Kimberly H Kim, Woojin Kim, Thomas P Howard, Francisca Vazquez, Aviad Tsherniak, Jennifer N Wu, Weishan Wang, Jeffrey R Haswell, Loren D Walensky, William C Hahn,[...]. Nat Med 2015
257
15


Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers.
Benjamin G Bitler, Katherine M Aird, Azat Garipov, Hua Li, Michael Amatangelo, Andrew V Kossenkov, David C Schultz, Qin Liu, Ie-Ming Shih, Jose R Conejo-Garcia,[...]. Nat Med 2015
403
15

The polycomb group protein EZH2 is involved in progression of prostate cancer.
Sooryanarayana Varambally, Saravana M Dhanasekaran, Ming Zhou, Terrence R Barrette, Chandan Kumar-Sinha, Martin G Sanda, Debashis Ghosh, Kenneth J Pienta, Richard G A B Sewalt, Arie P Otte,[...]. Nature 2002
15

Synovial sarcoma is a stem cell malignancy.
Norifumi Naka, Satoshi Takenaka, Nobuhito Araki, Toshitada Miwa, Nobuyuki Hashimoto, Kiyoko Yoshioka, Susumu Joyama, Ken-Ichiro Hamada, Yoshitane Tsukamoto, Yasuhiko Tomita,[...]. Stem Cells 2010
139
15

The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma.
Ana Banito, Xiang Li, Aimée N Laporte, Jae-Seok Roe, Francisco Sanchez-Vega, Chun-Hao Huang, Amanda R Dancsok, Katerina Hatzi, Chi-Chao Chen, Darjus F Tschaharganeh,[...]. Cancer Cell 2018
58
15

Reduced expression of SMARCB1/INI1 protein in synovial sarcoma.
Kenichi Kohashi, Yoshinao Oda, Hidetaka Yamamoto, Sadafumi Tamiya, Hiroshi Matono, Yukihide Iwamoto, Tomoaki Taguchi, Masazumi Tsuneyoshi. Mod Pathol 2010
87
13

EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity.
John E Campbell, Kevin W Kuntz, Sarah K Knutson, Natalie M Warholic, Heike Keilhack, Tim J Wigle, Alejandra Raimondi, Christine R Klaus, Nathalie Rioux, Akira Yokoi,[...]. ACS Med Chem Lett 2015
81
13

A novel fusion gene, SYT-SSX4, in synovial sarcoma.
B Skytting, G Nilsson, B Brodin, Y Xie, J Lundeberg, M Uhlén, O Larsson. J Natl Cancer Inst 1999
198
13

Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia.
Bowen Xu, Doan M On, Anqi Ma, Trevor Parton, Kyle D Konze, Samantha G Pattenden, David F Allison, Ling Cai, Shira Rockowitz, Shichong Liu,[...]. Blood 2015
150
13

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.
Winette T A van der Graaf, Jean-Yves Blay, Sant P Chawla, Dong-Wan Kim, Binh Bui-Nguyen, Paolo G Casali, Patrick Schöffski, Massimo Aglietta, Arthur P Staddon, Yasuo Beppu,[...]. Lancet 2012
13

Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.
Louis Guillou, Jean Benhattar, Françoise Bonichon, Gabrielle Gallagher, Philippe Terrier, Edouard Stauffer, Nicolas de Saint Aubain Somerhausen, Jean-Jacques Michels, Gernot Jundt, Dominique Ranchère Vince,[...]. J Clin Oncol 2004
211
13

Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2).
Yi-Che Changchien, Péter Tátrai, Gergő Papp, Johanna Sápi, László Fónyad, Miklós Szendrői, Zsuzsanna Pápai, Zoltán Sápi. J Transl Med 2012
32
15

Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: an analysis of 1268 patients.
Iyad Sultan, Carlos Rodriguez-Galindo, Raya Saab, Sameer Yasir, Michela Casanova, Andrea Ferrari. Cancer 2009
182
13

Targeting the Wnt pathway in synovial sarcoma models.
Whitney Barham, Andrea L Frump, Taylor P Sherrill, Christina B Garcia, Kenyi Saito-Diaz, Michael N VanSaun, Barbara Fingleton, Linda Gleaves, Darren Orton, Mario R Capecchi,[...]. Cancer Discov 2013
51
13

Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation.
Wei Qi, HoMan Chan, Lin Teng, Ling Li, Shannon Chuai, Ruipeng Zhang, Jue Zeng, Min Li, Hong Fan, Ying Lin,[...]. Proc Natl Acad Sci U S A 2012
409
13


Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma.
Gerard L Brien, David Remillard, Junwei Shi, Matthew L Hemming, Jonathon Chabon, Kieran Wynne, Eugène T Dillon, Gerard Cagney, Guido Van Mierlo, Marijke P Baltissen,[...]. Elife 2018
69
13

Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy.
Torsten O Nielsen, Neal M Poulin, Marc Ladanyi. Cancer Discov 2015
96
10

Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma.
A J Crew, J Clark, C Fisher, S Gill, R Grimer, A Chand, J Shipley, B A Gusterson, C S Cooper. EMBO J 1995
364
10

Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas.
Christopher J Sneeringer, Margaret Porter Scott, Kevin W Kuntz, Sarah K Knutson, Roy M Pollock, Victoria M Richon, Robert A Copeland. Proc Natl Acad Sci U S A 2010
463
10

SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes.
Evelien Middeljans, Xi Wan, Pascal W Jansen, Vikram Sharma, Hendrik G Stunnenberg, Colin Logie. PLoS One 2012
79
10

Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas.
Pauline Lagarde, Joanna Przybyl, Céline Brulard, Gaëlle Pérot, Gaelle Pierron, Olivier Delattre, Raf Sciot, Agnieszka Wozniak, Patrick Schöffski, Philippe Terrier,[...]. J Clin Oncol 2013
108
10

Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.
Arjen H G Cleven, Ghadah A Al Sannaa, Inge Briaire-de Bruijn, Davis R Ingram, Matt van de Rijn, Brian P Rubin, Maurits W de Vries, Kelsey L Watson, Keila E Torres, Wei-Lien Wang,[...]. Mod Pathol 2016
113
10

SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas.
Francois Le Loarer, Sarah Watson, Gaelle Pierron, Vincent Thomas de Montpreville, Stelly Ballet, Nelly Firmin, Aurelie Auguste, Daniel Pissaloux, Sandrine Boyault, Sandrine Paindavoine,[...]. Nat Genet 2015
173
10

PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies.
Thomas De Raedt, Eline Beert, Eric Pasmant, Armelle Luscan, Hilde Brems, Nicolas Ortonne, Kristian Helin, Jason L Hornick, Victor Mautner, Hildegard Kehrer-Sawatzki,[...]. Nature 2014
299
10

The Polycomb complex PRC2 and its mark in life.
Raphaël Margueron, Danny Reinberg. Nature 2011
10

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.
I Versteege, N Sévenet, J Lange, M F Rousseau-Merck, P Ambros, R Handgretinger, A Aurias, O Delattre. Nature 1998
10

TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.
Jefferson Terry, Tsuyoshi Saito, Subbaya Subramanian, Cindy Ruttan, Cristina R Antonescu, John R Goldblum, Erinn Downs-Kelly, Christopher L Corless, Brian P Rubin, Matt van de Rijn,[...]. Am J Surg Pathol 2007
219
10

Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution.
Andrea Ferrari, Alessandro Gronchi, Michela Casanova, Cristina Meazza, Lorenza Gandola, Paola Collini, Laura Lozza, Rossella Bertulli, Patrizia Olmi, Paolo G Casali. Cancer 2004
247
10

Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity.
J J Lewis, C R Antonescu, D H Leung, D Blumberg, J H Healey, J M Woodruff, M F Brennan. J Clin Oncol 2000
222
10


EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas.
Faizaan Mohammad, Simon Weissmann, Benjamin Leblanc, Deo P Pandey, Jonas W Højfeldt, Itys Comet, Chunqin Zheng, Jens Vilstrup Johansen, Nicolas Rapin, Bo T Porse,[...]. Nat Med 2017
268
10

An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1.
Kyle D Konze, Anqi Ma, Fengling Li, Dalia Barsyte-Lovejoy, Trevor Parton, Christopher J Macnevin, Feng Liu, Cen Gao, Xi-Ping Huang, Ekaterina Kuznetsova,[...]. ACS Chem Biol 2013
303
10

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.
Thomas Ernst, Andrew J Chase, Joannah Score, Claire E Hidalgo-Curtis, Catherine Bryant, Amy V Jones, Katherine Waghorn, Katerina Zoi, Fiona M Ross, Andreas Reiter,[...]. Nat Genet 2010
845
10

EZH2 inhibitor efficacy in non-Hodgkin's lymphoma does not require suppression of H3K27 monomethylation.
William D Bradley, Shilpi Arora, Jennifer Busby, Srividya Balasubramanian, Victor S Gehling, Christopher G Nasveschuk, Rishi G Vaswani, Chih-Chi Yuan, Charlie Hatton, Feng Zhao,[...]. Chem Biol 2014
99
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.